NEWS
Click here to access the latest ELN Newsletter Number 10 - February 2014
(previous newsletters number 9 (February 2013) and number 8 (February 2012) are accessible here as well)
ESF-ELN RNP article published in the ELN Newsletter 2011 click here
The Czechh Leukemia Study Group for Life (CZ-CELL) and the Haimaom Foundation decided in 2012 to withdraw their support to the RNP considering the economic possibilities in connection with the present economic crisis and the health reforms in their country.
Click on the ELN LeukemiaNet website
Summary
Treatment of leukemias has emerged as one of the most challenging areas in oncology. As leukemia therapy is complex, networking offers synergy effects and problem-solving potential. The European LeukemiaNet (ELN) funded by the 6th European Union Framework Programme since 2004 has set up a network for research, treatment and diagnostics in the field of leukemia with 175 participating institutions in 33 countries. The aim of the network is to make leukemia a curable disease. The ELN offers a collaborative action across Europe: 1) Central services via a Network Management Center (NMC), a European Leukemia Information Center (ELIC) and Central Information and Communication Services (CICS); 2) Promotion of European registries for leukemia and preleukemic disorders; 3) Performance of clinical trials on a European scale; 4) Development of guidelines and management recommendations for treatment and molecular monitoring of leukemias, for morphological diagnosis, gene profiling, microarray analyses, indications for stem cell transplantation and for infections in neutropenic patients; 5) Integration of member countries by exchange visits, organisation of meetings, conferences, workshops and symposia; 6) Spread of Excellence, to raise awareness of the network, through targeted information material and meetings; 7) Development of public-private partnerships between ELN and industry. The ELN provides the tools to foster leukemia research and promote public health care in the field of leukemia across Europe.
More information available at: www.leukemia-net.org
Duration
5 years, from July 2010 to June 2015 (08-RNP-071)
